Biotech investors often chase early-stage companies in the hope that a single breakthrough trial will deliver massive returns ...

Across all industries, the total number of companies on track to go public could make this week the most active for IPOs ...

The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as a ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Over the past decade, 32% of innovative drug approvals were sponsored by emerging biotech companies, suggesting that they are ...

Cantai launched in 2023 with a $3 million seed round. The company has raised $6.55 million to date at an undisclosed valuation, according to PitchBook. It develops drug candidates with special ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

11 companies raised US$4 billion in Hong Kong in the first three weeks of 2026, with hundreds more lining up to list, Bonnie Chan says New energy, artificial intelligence, electric vehicle (EV) and ...

By giving small and mid-size biotechs access to real-world data and advanced analytics once reserved for large pharma, AI ...